Gaurav S.

Gaurav S. is an accomplished executive with extensive experience in the pharmaceutical and clinical research sectors. Currently serving as VP of Clinical Portfolio Services at Alnylam Pharmaceuticals since April 2024, Gaurav previously held multiple leadership roles at Takeda from June 2020 to April 2024, including VP and Head of Clinical Partner Management. Earlier, Gaurav was Vice President and Global Head of Account Management & Shared Services at Parexel, where responsibilities included leading global alliance management and overseeing commercial support functions. Gaurav's tenure at Parexel featured roles such as VP of Enterprise Account and Partnership Center of Excellence, VP of Clinical Research Services, and VP of Medical Affairs & Innovation, demonstrating a strong focus on client delivery and therapeutic expansion. Gaurav's career began with positions at Abbott Diabetes Care and Armstrong Pharmaceuticals, highlighting a solid foundation in project management and product development. Gaurav holds an MBA from Babson F.W. Olin Graduate School of Business and a Bachelor's degree from Northeastern University.